Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats

被引:37
|
作者
Boesen, Erika I. [1 ]
Williams, Douglas L. [1 ]
Pollock, Jennifer S. [1 ]
Pollock, David M. [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
基金
美国国家卫生研究院;
关键词
hypertension; kidney; macrophage; mineralocorticoid; T-lymphocyte; IMMUNE CELL INFILTRATION; ANGIOTENSIN-II; SENSITIVE HYPERTENSION; BLOOD-PRESSURE; RENAL DAMAGE; MINERALOCORTICOID RECEPTORS; ARTERIAL-PRESSURE; OXIDATIVE STRESS; T-CELL; KIDNEY;
D O I
10.1111/j.1440-1681.2010.05428.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P>1. The interplay between the immune and renin-angiotensin systems is emerging as a crucial factor in the development and progression of hypertension. The aim of the present study was to determine the involvement of immune cells in the hypertension and renal injury produced by a non-angiotensin II-dependent form of hypertension, namely deoxycorticosterone acetate (DOCA)-salt-induced hypertension, in rats. 2. Male Sprague-Dawley rats underwent uninephrectomy and received either a sustained-release pellet of DOCA s.c. and 0.9% NaCl (saline) to drink for 21 days or a placebo pellet and water to drink for 21 days. Additional groups of DOCA-salt- and placebo-treated rats were treated concurrently with the immune suppressant mycophenolate mofetil (MMF; 30 mg/kg per day). Rats were placed in metabolic cages for 24 h urine collection prior to and at weekly intervals during the 21 day experimental period. 3. Mycophenolate mofetil significantly attenuated the development of hypertension in DOCA-salt rats compared with untreated DOCA-salt hypertensive rats (mean arterial pressure by telemetry on Day 18 146 +/- 7 vs 180 +/- 3 mmHg, respectively; P < 0.001), as well as proteinuria (87 +/- 27 vs 305 +/- 63 mg/day, respectively, on Day 21) and albuminuria (51 +/- 15 vs 247 +/- 73 mg/day, respectively, on Day 21). Creatinine clearance was better preserved in MMF-treated DOCA-salt rats compared with untreated DOCA-salt rats (0.74 +/- 0.07 vs 0.49 +/- 0.09 mL/min, respectively; P < 0.05), but was still significantly reduced compared with that in the placebo group (1.15 +/- 0.12 mL/min; P < 0.05). Finally, MMF treatment significantly attenuated the DOCA-salt-induced rise in renal cortical T-lymphocyte and macrophage infiltration (P < 0.05). 4. These data indicate that immune cells play a deleterious role in both the hypertension and renal injury associated with DOCA-salt hypertension.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [41] Hemodynamic effects of a selective endothelin-A receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats
    Yu, M
    Gopalakrishnan, V
    McNeill, JR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S262 - S264
  • [42] Regional differences of vasoconstrictor response to uridine adenosine tetraphosphate in deoxycorticosterone acetate-salt hypertensive rats
    Matsumoto, Takayuki
    Tostes, Rita C.
    Webb, R. Clinton
    FASEB JOURNAL, 2011, 25
  • [43] ALTERED CATIONS AND MUSCLE MEMBRANE ATPASE ACTIVITY IN DEOXYCORTICOSTERONE ACETATE-SALT SPONTANEOUSLY HYPERTENSIVE RATS
    TOUYZ, RM
    MARSHALL, PR
    MILNE, FJ
    JOURNAL OF HYPERTENSION, 1991, 9 (08) : 737 - 750
  • [44] Endothelin-1 signaling is altered in cardiac cells from deoxycorticosterone acetate-salt hypertensive rats
    Touyz, RM
    Fareh, J
    Thibault, G
    Schiffrin, EL
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S179 - S181
  • [45] Antihypertensive and Renoprotective Effects of Dietary Flaxseed and its Mechanism of Action in Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Watanabe, Yusuke
    Ohata, Kaori
    Fukanoki, Ayaka
    Fujimoto, Naoto
    Matsumoto, Maruri
    Nessa, Naseratun
    Toba, Hiroe
    Kobara, Miyuki
    Nakata, Tetsuo
    PHARMACOLOGY, 2020, 105 (1-2) : 54 - 62
  • [46] Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension
    Korshunov, Vyacheslav A.
    Daul, Matthew
    Massett, Michael P.
    Berk, Bradford C.
    HYPERTENSION, 2007, 50 (06) : 1057 - 1062
  • [47] SEPARATE HEMODYNAMIC ROLES FOR CHLORIDE AND SODIUM IN DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSION
    PASSMORE, JC
    JIMENEZ, AE
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1990, 194 (03): : 283 - 288
  • [48] Glomerular thromboxane contributes to pressor response in deoxycorticosterone acetate-salt hypertension
    Kosugi, T
    Ikeda, T
    Gomi, T
    Ushijima, T
    Okada, J
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1998, 58 (02): : 129 - 133
  • [49] Effect of an endothelin antagonist on vascular responsiveness to vasopressin and angiotensin II in deoxycorticosterone acetate-salt hypertensive rats
    McNeill, JR
    Yu, M
    Gopalakrishnan, V
    JOURNAL OF HYPERTENSION, 2000, 18 : S131 - S131
  • [50] Effect of trichlormethiazide and captopril on nitric oxide synthase activity in the kidney of deoxycorticosterone acetate-salt hypertensive rats
    Takanohashi, A
    Tojo, A
    Kobayashi, N
    Yagi, S
    Matsuoka, H
    JAPANESE HEART JOURNAL, 1996, 37 (02): : 251 - 259